Humoral Determinants of Immunity to Pneumococcal Infection

Summary

The purpose of this study is to determine whether there are differences in the level of antibody to capsular polysaccharides of S. pneumoniae or the physiological activity of such antibody after vaccinating patients who have recovered from pneumococcal pneumonia with pneumococcal polysaccharide vaccine (Pneumovax) or conjugate pneumococcal vaccine (Prevnar).

Timeline

Start

2003-01-01

Primary completion

2006-09-01

Completion

2012-06-01

Drugs

Indications